3.連結財務諸表及び主な注記
(1)連結貸借対照表
|
|
|
|
|
|
|
|
|
|
|
|
(単位:千円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年2月28日)
|
当連結会計年度
(2026年2月28日)
|
|
資産の部
|
|
|
|
|
流動資産
|
|
|
|
|
|
現金及び預金
|
6,768,998
|
6,121,536
|
|
|
|
受取手形
|
7,439
|
11,410
|
|
|
|
売掛金
|
7,478,539
|
8,361,680
|
|
|
|
商品
|
2,215,859
|
2,361,345
|
|
|
|
その他
|
1,500,685
|
2,300,691
|
|
|
|
貸倒引当金
|
△6,487
|
△10,254
|
|
|
|
流動資産合計
|
17,965,034
|
19,146,409
|
|
|
固定資産
|
|
|
|
|
|
有形固定資産
|
|
|
|
|
|
|
建物及び構築物
|
13,676,578
|
14,555,807
|
|
|
|
|
|
減価償却累計額
|
△7,687,419
|
△8,055,746
|
|
|
|
|
|
建物及び構築物(純額)
|
5,989,158
|
6,500,060
|
|
|
|
|
車両運搬具
|
141,377
|
132,530
|
|
|
|
|
|
減価償却累計額
|
△97,863
|
△86,054
|
|
|
|
|
|
車両運搬具(純額)
|
43,513
|
46,475
|
|
|
|
|
工具、器具及び備品
|
1,762,562
|
1,932,016
|
|
|
|
|
|
減価償却累計額
|
△1,465,575
|
△1,552,246
|
|
|
|
|
|
工具、器具及び備品(純額)
|
296,987
|
379,770
|
|
|
|
|
土地
|
3,588,121
|
3,847,313
|
|
|
|
|
建設仮勘定
|
124,233
|
132,475
|
|
|
|
|
有形固定資産合計
|
10,042,014
|
10,906,096
|
|
|
|
無形固定資産
|
|
|
|
|
|
|
のれん
|
816,413
|
774,657
|
|
|
|
|
その他
|
173,199
|
162,630
|
|
|
|
|
無形固定資産合計
|
989,612
|
937,288
|
|
|
|
投資その他の資産
|
|
|
|
|
|
|
投資有価証券
|
2,405,444
|
3,316,934
|
|
|
|
|
繰延税金資産
|
521,054
|
517,237
|
|
|
|
|
敷金及び保証金
|
1,167,481
|
1,052,460
|
|
|
|
|
その他
|
1,141,133
|
1,646,987
|
|
|
|
|
投資その他の資産合計
|
5,235,113
|
6,533,619
|
|
|
|
固定資産合計
|
16,266,740
|
18,377,004
|
|
|
資産合計
|
34,231,775
|
37,523,413
|
|
|
|
|
|
|
|
|
|
|
|
|
(単位:千円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年2月28日)
|
当連結会計年度
(2026年2月28日)
|
|
負債の部
|
|
|
|
|
流動負債
|
|
|
|
|
|
支払手形
|
6,414
|
994
|
|
|
|
買掛金
|
5,440,590
|
5,755,710
|
|
|
|
電子記録債務
|
625,034
|
674,767
|
|
|
|
短期借入金
|
1,180,000
|
530,000
|
|
|
|
1年内返済予定の長期借入金
|
2,609,852
|
2,281,353
|
|
|
|
未払法人税等
|
535,143
|
374,104
|
|
|
|
賞与引当金
|
266,885
|
307,236
|
|
|
|
その他
|
1,004,744
|
1,693,506
|
|
|
|
流動負債合計
|
11,668,666
|
11,617,672
|
|
|
固定負債
|
|
|
|
|
|
社債
|
-
|
150,000
|
|
|
|
長期借入金
|
6,052,443
|
7,252,962
|
|
|
|
リース債務
|
175,552
|
150,105
|
|
|
|
退職給付に係る負債
|
1,100,344
|
1,086,186
|
|
|
|
その他
|
522,634
|
980,672
|
|
|
|
固定負債合計
|
7,850,975
|
9,619,926
|
|
|
負債合計
|
19,519,641
|
21,237,598
|
|
純資産の部
|
|
|
|
|
株主資本
|
|
|
|
|
|
資本金
|
917,000
|
917,000
|
|
|
|
資本剰余金
|
1,085,044
|
1,064,347
|
|
|
|
利益剰余金
|
12,391,773
|
12,797,102
|
|
|
|
自己株式
|
△531,724
|
△7,129
|
|
|
|
株主資本合計
|
13,862,094
|
14,771,321
|
|
|
その他の包括利益累計額
|
|
|
|
|
|
その他有価証券評価差額金
|
232,084
|
802,886
|
|
|
|
退職給付に係る調整累計額
|
3,682
|
57,907
|
|
|
|
その他の包括利益累計額合計
|
235,766
|
860,793
|
|
|
非支配株主持分
|
614,273
|
653,700
|
|
|
純資産合計
|
14,712,134
|
16,285,814
|
|
負債純資産合計
|
34,231,775
|
37,523,413
|
E03443
33530
株式会社メディカル一光グループ
Medical Ikkou Group Co.,Ltd.
通期第1号参考様式 [日本基準](連結)
Japan GAAP
true
cte
cte
2025-03-01
2026-02-28
FY
2026-02-28
2024-03-01
2025-02-28
2025-02-28
1
false
false
false
33530
2026-04-06
33530
2025-03-01
2026-02-28
33530
2025-03-01
2026-02-28
jppfs_cor:CapitalStockMember
33530
2025-03-01
2026-02-28
jppfs_cor:CapitalSurplusMember
33530
2025-03-01
2026-02-28
jppfs_cor:NonControllingInterestsMember
33530
2025-03-01
2026-02-28
jpcrp_cor:ReconcilingItemsMember
33530
2025-03-01
2026-02-28
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
33530
2025-03-01
2026-02-28
jppfs_cor:RetainedEarningsMember
33530
2025-03-01
2026-02-28
jppfs_cor:ShareholdersEquityMember
33530
2025-03-01
2026-02-28
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
33530
2025-03-01
2026-02-28
jppfs_cor:TreasuryStockMember
33530
2025-03-01
2026-02-28
tse-acedjpfr-33530:DispensingPharmacyReportableSegmentsMember
33530
2025-03-01
2026-02-28
tse-acedjpfr-33530:HealthCareReportableSegmentsMember
33530
2025-03-01
2026-02-28
tse-acedjpfr-33530:MedicalProductsWholesaleReportableSegmentsMember
33530
2025-03-01
2026-02-28
tse-acedjpfr-33530:RealEstateReportableSegmentsMember
33530
2025-03-01
2026-02-28
jpcrp_cor:UnallocatedAmountsAndEliminationMember
33530
2025-03-01
2026-02-28
jppfs_cor:ValuationAndTranslationAdjustmentsMember
33530
2025-03-01
2026-02-28
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
33530
2026-02-28
33530
2026-02-28
jppfs_cor:CapitalStockMember
33530
2026-02-28
jppfs_cor:CapitalSurplusMember
33530
2026-02-28
jppfs_cor:NonControllingInterestsMember
33530
2026-02-28
jpcrp_cor:ReconcilingItemsMember
33530
2026-02-28
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
33530
2026-02-28
jppfs_cor:RetainedEarningsMember
33530
2026-02-28
jppfs_cor:ShareholdersEquityMember
33530
2026-02-28
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
33530
2026-02-28
jppfs_cor:TreasuryStockMember
33530
2026-02-28
tse-acedjpfr-33530:DispensingPharmacyReportableSegmentsMember
33530
2026-02-28
tse-acedjpfr-33530:HealthCareReportableSegmentsMember
33530
2026-02-28
tse-acedjpfr-33530:MedicalProductsWholesaleReportableSegmentsMember
33530
2026-02-28
tse-acedjpfr-33530:RealEstateReportableSegmentsMember
33530
2026-02-28
jpcrp_cor:UnallocatedAmountsAndEliminationMember
33530
2026-02-28
jppfs_cor:ValuationAndTranslationAdjustmentsMember
33530
2026-02-28
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
33530
2024-03-01
2025-02-28
33530
2024-03-01
2025-02-28
jppfs_cor:CapitalStockMember
33530
2024-03-01
2025-02-28
jppfs_cor:CapitalSurplusMember
33530
2024-03-01
2025-02-28
jppfs_cor:NonControllingInterestsMember
33530
2024-03-01
2025-02-28
jpcrp_cor:ReconcilingItemsMember
33530
2024-03-01
2025-02-28
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
33530
2024-03-01
2025-02-28
jppfs_cor:RetainedEarningsMember
33530
2024-03-01
2025-02-28
jppfs_cor:ShareholdersEquityMember
33530
2024-03-01
2025-02-28
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
33530
2024-03-01
2025-02-28
jppfs_cor:TreasuryStockMember
33530
2024-03-01
2025-02-28
tse-acedjpfr-33530:DispensingPharmacyReportableSegmentsMember
33530
2024-03-01
2025-02-28
tse-acedjpfr-33530:HealthCareReportableSegmentsMember
33530
2024-03-01
2025-02-28
tse-acedjpfr-33530:MedicalProductsWholesaleReportableSegmentsMember
33530
2024-03-01
2025-02-28
tse-acedjpfr-33530:RealEstateReportableSegmentsMember
33530
2024-03-01
2025-02-28
jpcrp_cor:UnallocatedAmountsAndEliminationMember
33530
2024-03-01
2025-02-28
jppfs_cor:ValuationAndTranslationAdjustmentsMember
33530
2024-03-01
2025-02-28
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
33530
2025-02-28
33530
2025-02-28
jppfs_cor:CapitalStockMember
33530
2025-02-28
jppfs_cor:CapitalSurplusMember
33530
2025-02-28
jppfs_cor:NonControllingInterestsMember
33530
2025-02-28
jpcrp_cor:ReconcilingItemsMember
33530
2025-02-28
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
33530
2025-02-28
jppfs_cor:RetainedEarningsMember
33530
2025-02-28
jppfs_cor:ShareholdersEquityMember
33530
2025-02-28
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
33530
2025-02-28
jppfs_cor:TreasuryStockMember
33530
2025-02-28
tse-acedjpfr-33530:DispensingPharmacyReportableSegmentsMember
33530
2025-02-28
tse-acedjpfr-33530:HealthCareReportableSegmentsMember
33530
2025-02-28
tse-acedjpfr-33530:MedicalProductsWholesaleReportableSegmentsMember
33530
2025-02-28
tse-acedjpfr-33530:RealEstateReportableSegmentsMember
33530
2025-02-28
jpcrp_cor:UnallocatedAmountsAndEliminationMember
33530
2025-02-28
jppfs_cor:ValuationAndTranslationAdjustmentsMember
33530
2025-02-28
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
33530
2024-02-29
33530
2024-02-29
jppfs_cor:CapitalStockMember
33530
2024-02-29
jppfs_cor:CapitalSurplusMember
33530
2024-02-29
jppfs_cor:NonControllingInterestsMember
33530
2024-02-29
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
33530
2024-02-29
jppfs_cor:RetainedEarningsMember
33530
2024-02-29
jppfs_cor:ShareholdersEquityMember
33530
2024-02-29
jppfs_cor:TreasuryStockMember
33530
2024-02-29
jppfs_cor:ValuationAndTranslationAdjustmentsMember
33530
2024-02-29
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
iso4217:JPY
xbrli:pure